El cáncer de pulmón es por mucho la causa principal de muerte por cáncer entre hombres y mujeres, representando casi un 25% de todas las muertes por cáncer.
La Comercializadora de Servicios Médicos Cubanos, S.A. ofrece un tratamiento integral para personas con cáncer de pulmón de células no pequeñas en estadios avanzados (IIIB y IV), que hayan recibido radioterapia y quimioterapia, se encuentren estables, y hayan concluido esta primera línea de tratamiento oncológico al menos 4 semanas antes, con la vacuna terapéutica VaxiraLung cancer is by far the leading cause of cancer death among men and women, accounting for almost 25% of all cancer deaths.
Comercializadora de Servicios Médicos Cubanos, S.A. provides a comprehensive treatment for people with non-small cell lung cancer in advanced stages (IIIB and IV), who have received radiotherapy and chemotherapy, are stable, and have concluded this first line of oncologic treatment at least 4 weeks before, with the therapeutic vaccine Vaxira®.
The vaccine is a scientific result of Cuban biotechnology, of great international prestige, with excellent benefits in Cuban patients and in many other countries.
Treatment with Vaxira® allows controlling the growth of the tumor and increases the person's life expectancy. It also improves the quality of life and the symptoms of the disease, making the patient feel physically and emotionally better.
The treatment requires admission with a companion. It is administered subcutaneously. It consists of an induction phase in which five doses are applied (one every 14 days) and a second maintenance phase that includes re-immunizations every 28 days, which will be maintained until the patient's condition allows it.
In the Cuban oncology services that offer this program, the patient is evaluated by multidisciplinary teams (nationally certified and internationally endorsed) made up of internists, radiologists, pathologists, hematologists, surgeons, among others, presided over by a clinical oncologist. These specialists are responsible for establishing personalized treatment according to the diagnosis and stage of the cancer.
To begin treatment, you should contact the Coordination and Processing Center of Comercializadora de Servicios Médicos Cubanos, S.A. at smc@smcsalud.cu. You will be sent the medical program with its costs.
La Comercializadora de Servicios Médicos Cubanos, S.A. ofrece un tratamiento integral para personas con cáncer de pulmón de células no pequeñas en estadios avanzados (IIIB y IV), que hayan recibido radioterapia y quimioterapia, se encuentren estables, y hayan concluido esta primera línea de tratamiento oncológico al menos 4 semanas antes, con la vacuna terapéutica VaxiraLung cancer is by far the leading cause of cancer death among men and women, accounting for almost 25% of all cancer deaths.
Comercializadora de Servicios Médicos Cubanos, S.A. provides a comprehensive treatment for people with non-small cell lung cancer in advanced stages (IIIB and IV), who have received radiotherapy and chemotherapy, are stable, and have concluded this first line of oncologic treatment at least 4 weeks before, with the therapeutic vaccine Vaxira®.
The vaccine is a scientific result of Cuban biotechnology, of great international prestige, with excellent benefits in Cuban patients and in many other countries.
Treatment with Vaxira® allows controlling the growth of the tumor and increases the person's life expectancy. It also improves the quality of life and the symptoms of the disease, making the patient feel physically and emotionally better.
The treatment requires admission with a companion. It is administered subcutaneously. It consists of an induction phase in which five doses are applied (one every 14 days) and a second maintenance phase that includes re-immunizations every 28 days, which will be maintained until the patient's condition allows it.
In the Cuban oncology services that offer this program, the patient is evaluated by multidisciplinary teams (nationally certified and internationally endorsed) made up of internists, radiologists, pathologists, hematologists, surgeons, among others, presided over by a clinical oncologist. These specialists are responsible for establishing personalized treatment according to the diagnosis and stage of the cancer.
To begin treatment, you should contact the Coordination and Processing Center of Comercializadora de Servicios Médicos Cubanos, S.A. at smc@smcsalud.cu. You will be sent the medical program with its costs.